PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 4.244
EU - Europa 2.871
AS - Asia 1.702
AF - Africa 252
OC - Oceania 9
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.088
Nazione #
US - Stati Uniti d'America 4.231
GB - Regno Unito 747
IT - Italia 697
CN - Cina 575
SG - Singapore 434
VN - Vietnam 414
DE - Germania 345
SE - Svezia 282
UA - Ucraina 203
IE - Irlanda 177
IN - India 151
FR - Francia 122
RU - Federazione Russa 102
CI - Costa d'Avorio 91
TG - Togo 72
ZA - Sudafrica 63
EE - Estonia 59
JO - Giordania 48
BG - Bulgaria 31
FI - Finlandia 21
BE - Belgio 20
CH - Svizzera 17
IR - Iran 17
NL - Olanda 15
CA - Canada 13
ID - Indonesia 12
JP - Giappone 12
SC - Seychelles 12
NG - Nigeria 11
AU - Australia 7
BR - Brasile 7
TR - Turchia 6
AT - Austria 5
GR - Grecia 5
HK - Hong Kong 5
KR - Corea 5
PH - Filippine 5
PK - Pakistan 5
PL - Polonia 5
LB - Libano 4
CZ - Repubblica Ceca 3
HR - Croazia 3
MK - Macedonia 3
AL - Albania 2
BD - Bangladesh 2
EG - Egitto 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 9.088
Città #
Southend 677
Chandler 513
Fairfield 501
Singapore 387
Ashburn 309
Santa Clara 263
Wilmington 246
Woodbridge 240
Dong Ket 197
Houston 188
Princeton 180
Seattle 180
Dublin 177
Cambridge 172
Ann Arbor 156
Boardman 112
Bologna 109
Jacksonville 93
Abidjan 91
Padova 77
Nanjing 74
Westminster 74
Lomé 72
Turin 61
Milan 57
Beijing 53
Berlin 50
Amman 48
Jinan 39
Shenyang 38
San Diego 33
Medford 29
Saint Petersburg 29
Sofia 29
Hebei 27
Jiaxing 26
Guangzhou 24
Nanchang 22
Brussels 20
Changsha 20
Des Moines 20
Helsinki 19
Mülheim 18
Dearborn 16
Shanghai 16
Falls Church 15
Hangzhou 14
Olalla 14
Rome 14
Zhengzhou 13
Florence 12
Jakarta 12
Los Angeles 12
Redmond 12
Tianjin 12
Abeokuta 11
Bern 11
Mahé 11
New York 11
Taizhou 11
Bremen 10
Ningbo 10
London 9
Monmouth Junction 9
Norwalk 9
Redwood City 9
Tokyo 9
Amsterdam 8
Ardabil 8
Cernusco sul Naviglio 8
Chengdu 8
Paris 8
Bühl 7
Haikou 7
Moscow 7
Napoli 7
Palermo 7
Reggio Emilia 7
Taiyuan 7
Andover 6
Beauharnois 6
Genoa 6
Kunming 6
Perugia 6
Shenzhen 6
Verona 6
Buffalo 5
Naples 5
Phoenix 5
San Pablo City 5
Zanjan 5
Baoding 4
Casalgrande 4
Dongguan 4
Fermo 4
Foshan 4
Frankfurt Am Main 4
Fuzhou 4
Harbin 4
Hong Kong 4
Totale 6.224
Nome #
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 208
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 180
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 175
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 172
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 169
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 165
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 161
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 158
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 156
Pulmonary Arterial Hypertension associated to connective tissue diseases 153
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 145
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 142
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 142
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 137
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 136
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 136
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 130
Challenges in pulmonary hypertension: Managing the unexpected 129
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 129
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 128
Current therapeutic approaches to pulmonary arterial hypertension. 127
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 122
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 122
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 119
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 118
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 113
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 113
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 112
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 111
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 110
Sildenafil therapy in patients with porto-pulmonary hypertension 110
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 110
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 110
The difficult diagnosis of pulmonary vascular disease in heart failure 110
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 109
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 108
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 107
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 106
Cardiologia pediatrica. Problematiche cliniche 106
Long-term therapeutic outcomes in pulmonary arterial hypertension 105
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 105
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 104
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 103
Pulmonary veno-occlusive disease: the role of CT 103
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 102
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 102
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 100
Current medical therapies in pulmonary arterial hypertension 99
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 98
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 98
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 97
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 96
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 96
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 95
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 94
Conventional Medical Therapies in the treatment of pulmonary hypertension 92
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 92
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 92
Pulmonary hypertension 91
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 88
Pulmonary hypertension due to left heart disease 88
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 87
[Treatment goals of pulmonary hypertension]. 87
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 87
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 87
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 86
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 85
The burden of comorbidities in pulmonary arterial hypertension 85
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 85
Epidemiology of patients referred to a specialised pulmonary hypertension center 82
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 82
Experience with inheritable pulmonary arterial hypertension in a specialised center 80
Treatment goals of pulmonary hypertension. 77
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 77
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 74
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 74
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 73
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 71
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 71
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 68
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 63
Pulmonary Hypertension: Lessons from Adults 61
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 61
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 50
Long-term outcomes after pulmonary endarterectomy 50
Progressi nel trattamento delle malattie della circolazione polmonare 42
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 30
Chronic thromboembolic pulmonary disease 20
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 13
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 13
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 12
Extrinsic Compression Of The Left Main Coronary Artery By Enlarged Pulmonary Artery In Patients With Pulmonary Arterial Hypertension 12
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 11
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 11
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 11
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 9
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 8
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 7
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 7
Totale 9.343
Categoria #
all - tutte 24.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.344 0 0 0 0 0 195 236 296 279 151 88 99
2020/20211.267 217 71 32 60 27 100 24 58 121 54 47 456
2021/20221.603 139 80 106 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20251.377 79 384 259 162 396 97 0 0 0 0 0 0
Totale 9.343